Evidence map›Paper›PMID 35597133›Full record

ArticleSchizophrenia research2022

Considerations for providing feedback to patients and families regarding clinical high-risk for psychosis status.

Jason Schiffman, Leslie E Horton, Yulia Landa, Scott W Woods

Abstract readComment
PubMed Publisher
In one paragraph

Article in Schizophrenia research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Synergistic pathways to psychosis: understanding developmental risk and resilience factors.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  4. Article
  5. Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Jason SchiffmanUniversity of California, Irvine, United States of America. Electronic address: jason.schiffma@uci.edu.
Leslie E HortonUniversity of Pittsburgh Department of Psychiatry, United States of America.
Yulia LandaIcahn School of Medicine at Mount Sinai, United States of America.
Scott W WoodsDepartment of Psychiatry, Yale University, United States of America.

Funding

ProNET: Psychosis-Risk Outcomes NetworkU01MH124639 · NIMH · YALE UNIVERSITY · PI CARRIE E BEARDEN, JOHN M KANE · 2020 to 2026
$81.2M
Administrative Supplement - 3/3: Community Psychology Risk Screening: An Instrument Development StudyR01MH112612 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI PITTS, STEVEN C, SCHIFFMAN, JASON E · 2017 to 2022
$1.3M
Early Stage Identification and Engagement to Reduce Duration of Untreated Psychosis (EaSIE)R34MH115463 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LANDA, YULIA · 2017 to 2019
$792k
NIMH NIH HHS R01 MH112612NIMH NIH HHS R34 MH115463NIMH NIH HHS U01 MH124639
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Psychotic DisordersFeedbackHumansSocial StigmaClinical feedbackClinical high-riskFamilyLived experienceRecoveryStigma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.